Autophagy and apoptosis function as important early cellular defense mechanisms in infections and other diseases. The outcome of an infection is determined by a complex interplay between the pathogenic microorganism and these intracellular pathways. To better understand the cytopathogenicity of Herpes simplex virus types 1 and 2 (HSV-1 and -2), we studied the effect of these viruses on the autophagic and apoptotic processes in the SIRC corneal cell line. Infection with the KOS strain of HSV-1 and a wild-type strain of HSV-2 enhanced autophagosome formation, triggered cytoplasmic acidification, increased LC3B lipidation and elevated the ratio of apoptotic cells. The autophagy inhibitor bafilomycin A1 triggered a significant increase in the apoptotic responses of HSV-1-and HSV-2-infected cells. Thus, both HSV types affect autophagy and apoptosis in a coordinated fashion, and autophagy plays cytoprotective role in HSV-infected cells via antagonizing apoptosis. Together these data implicate autophagy in the pathogenic mechanism of herpetic keratitis.
Introduction
Herpes simplex virus types 1 and 2 (HSV-1 and -2) belonging to the Herpesviridae family of large, enveloped DNA viruses are capable of causing a wide array of human diseases, including herpes simplex labialis, genital herpes, encephalitis and ocular diseases, such as blepharitis, conjunctivitis, keratitis, iridocyclitis and acute retinal necrosis (Roizman and Pellett 2001; Vemuganti et al. 2011; Babu et al. 2013; Rowe et al. 2013; Silva et al. 2013) . During the course of herpetic keratitis, the HSV-induced cytopathogenicity together with the chronic immune-inflammatory reaction can trigger stromal scarring, thinning and neovascularization, leading to permanent vision impairment. Herpetic keratitis therefore remains a frequent infectious cause of blindness in many countries (Biswas and Rouse 2005; Choudhary et al. 2008; Rowe et al. 2013) .
Tissue damage elicited by HSV-1 and -2 displays cell-type-specific features. These viruses cause a lytic infection in the epithelial cells and elicit tissue destruction characterized by complex cell death pattern (Roizman and Pellett 2001; Nguyen and Blaho 2007) . In consequence of acquisition, HSV-1 and HSV-2 establish lifelong latency, inhibit apoptosis and maintain cell survival within the neurons (Roizman and Pellett 2001) . Systemic and local stressors can interrupt the latency and induce viral reactivation, leading to recrudescent infections. The cytopathogenic mechanism of diseases caused by HSV-1 and HSV-2 involves indirect, immune processes and direct, virus-mediated events (Biswas and Rouse 2005; Holdeman 2005 ; Kaye and Choudhary 2006; Fatahzadeh and Schwartz 2007; Choudhary et al. 2008) .
Multiplication of these viruses subverts the physiological regulation of apoptotic cell demise Blaho 2007 and 2009 ). Apoptosis, termed type I programmed cell death, is a type of cell deletion characterized by stereotypic cytomorphological changes, such as nuclear compaction, DNA fragmentation to nucleosomesized fragments and cell shrinkage resulting in cellular breakdown into membrane-bound apoptotic bodies. The molecular events implicated in the activation of apoptotic cascade can be mediated by intrinsic and extrinsic cellular pathways (Nguyen and Blaho 2009) . It has been shown that early in infection with HSV-1 or HSV-2, the appearance of viral immediate early (IE) mRNAs activates the cellular apoptotic machinery. However, at 3 to 6 hours post-infection (hpi), several anti-apoptotic HSV proteins [Infected Cell Protein 4 (ICP4), ICP22, ICP17, ICP34.5, US3, US5, US6, UL14 and ICP10 of HSV-2], as well as the latency-associated transcript inhibit apoptotic demise, and maintain cell survival until the replication cycle is completed (Megyeri 2007) . The time period while anti-apoptotic HSV proteins are synthesized is termed 'apoptosis prevention window' (Goodkin et al. 2003) . In this phase of infection, the intricate balance of pro-and anti-apoptotic factors is strongly biased by the indirect influence of powerful cellular defense pathways, such as the DNA damage response pathway or the interferon system (Shirata et al. 2005) . Finally, HSV multiplication leads to the inevitable death of host cells, at least in part via apoptotic mechanisms. Apoptosis fulfils dual functions in the pathogenic mechanism of diseases caused by HSV-1 and HSV-2; it contributes to tissue damage and exerts antiviral effect by inhibiting viral spread at the expense of killing infected cells.
HSV-1 and HSV-2 are also capable of modulating autophagy, termed type II programmed cell death (Tallóczy et al. 2001; Tallóczy et al. 2006; McFarlane et al. 2011; Lussignol et al. 2013) . Autophagy is an essential catabolic process that maintains cellular integrity by degrading cytoplasmic constituents and organelles (Deretic and Levine 2009) . It is highly activated by several pathological conditions, including nutrient starvation, oxidative stress, inflammation and infections (Deretic and Levine 2009) . Macroautophagy (herein referred to as autophagy) is one of the three ways the cells can deliver sequestered cytoplasmic content, damaged proteins, organelles or pathogens to the lysosomal compartment using a double-membraned autophagosomal vacuole as a carrying vehicle (Deretic and Levine 2009) . Under conditions of mild stress, autophagy plays a cytoprotective role by eliminating pathogenic microorganisms and dysfunctional organelles. In contrast, under conditions leading to massive cell damage, excessive autophagy possesses destructive power culminating in cell demise (Chen and Klionsky 2011) . It has been shown that at the early stage of infection HSV-1 provokes autophagy (McFarlane et al. 2011) . However, some viral proteins (ICP34.5 and US11) synthesized during the subsequent phases of productive infection function as powerful inhibitors of the autophagic process (Tallóczy et al. 2001; Tallóczy et al. 2006; Orvedahl et al. 2007; Lussignol et al. 2013) . ICP34.5 of HSV-1 antagonizes autophagy by binding Beclin-1, and by blocking the double-stranded RNA-dependent protein kinase/eukaryotic translation initiation factor 2α (PKR/ eIF2α) pathway (Tallóczy et al. 2006; Orvedahl et al. 2007 ). The HSV-1 US11 protein exerts anti-autophagic activity via its direct interaction with PKR (Lussignol et al. 2013) . These interesting studies have shed light on the importance of autophagy in infections caused by HSV-1, and have successfully uncovered the underlying molecular mechanisms in some experimental systems. At present, much less is known about the effects of wildtype HSV-2 on autophagy.
Our group previously described the importance of apoptosis in the cytopathogenicity of HSV-1 and demonstrated the role of the pro-apoptotic p53 family member TAp63γ in the pathogenic mechanism of ocular surface disease caused by HSV-1 (Orosz et al. 2010) . To further understand the corneal processes induced by HSV-1 and HSV-2, in the present study we investigated the effects of these viruses on autophagy in the Statens Seruminstitut Rabbit Cornea (SIRC) cell line, which displays many features of corneal keratocytes (Niederkorn et al. 1990 ).
Materials and methods

Cell culture and HSV growth
The SIRC cell line, was grown in Dulbecco's modified Eagle's minimal essential medium (Sigma Chemical Co., St. Louis, MO, USA) supplemented with 10% fetal calf serum (FCS) at 37°C in a 5% CO 2 atmosphere. For experiments, SIRC cell cultures were inoculated with the KOS strain of HSV-1 or a wild-type strain of HSV-2 at different multiplicities of infection (MOIs). Virus plaque assays were performed on confluent monolayers of Vero cells inoculated with one or other HSV solution for 1 h at 37°C and overlaid with 0.5% agarose in phenol red-free Eagle's minimum essential medium supplemented with 7.5% FCS and 2 mM L-glutamine. Plaque titers were determined at 3 days after HSV infection.
Indirect immunofluorescence assay
Cytospin cell preparations were fixed in methanol-acetone (1:1) for 15 min at −20°C. The slides were incubated with specific antibodies to HSV glycoprotein D [(gD) (Sigma)], autophagy-related gene 5 (Atg5) or microtubule-associated protein 1 light chain 3B (LC3B) for 1 h at 37°C. After washing with phosphate-buffered saline (PBS), the samples were reacted with fluorescein isothiocyanate (FITC)-conjugated species-specific antibodies (1:160) (Sigma) and incubated for 1 h at 37°C. After washing with PBS, the cells were visualized by epifluorescence microscopy (Leica Microsystems GmbH, Wetzlar, Germany). The ratio of positive to negative cells was determined after counting 1,000 cells in random fields.
Transmission electron microscopy (TEM)
Samples were fixed in 0.1 M sodium cacodylate-buffered 2.5% glutaraldehyde solution (pH 7.4) for 2 h and then rinsed three times for 10 min each in 0.1 M sodium cacodylate buffer and 7.5% saccharose. The samples were post-fixed in 1% OsO 4 solution for 1 h. After dehydration in an ethanol gradient (70%, 96% and 100% ethanol for 20 min each), samples were embedded in Durcupan ACM. Ultrathin sections were stained with uranyl acetate and lead citrate. Sections were examined in a Philips CM 10 microscope (Philips Electronic Instruments, Mahwah, NJ, USA) at 80 kV.
Acridine orange staining
Autophagy was assessed by the acridine orange staining procedure of autophagic vacuoles. The cells, grown on glass coverslips were incubated for 15 min at 37°C in serum-free medium containing 2 μg/mL 3,6-bis(dimethylamine)acridine. After cells had been washed, fluorescent micrographs were obtained using an epifluorescence microscope (Leica Microsystems GmbH). Acridine orange accumulated by acidic compartments emits orange fluorescence, whereas this metachromatic dye bound to compartments with slightly acidic or neutral pH emits green fluorescence.
Quantification of apoptosis by annexin V/propidium iodide (AN/PI) double labelling
For AN/PI double labelling, the cells were stained with FITClabelled annexin V (AN-FITC) and propidium iodide (PI) (MBL, Woburn, MA, USA) according to the manufacturer's instructions. The fluorescence intensities of AN-FITC and PI were determined with a BD Bioscience flow cytometer (BD Biosciences, San Diego, CA, USA). The percentages of apoptotic cells were calculated by sorting the cells that were positive only for AN (early apoptotic stage) or for both AN and PI (late apoptotic or secondary necrotic stages).
Quantification of apoptosis by enzyme-linked immunosorbent assay (ELISA)
For apoptosis ELISA, the cells were processed in a cell death detection ELISA kit (Roche Diagnostics GmbH, Penzberg, Germany). The cells were incubated in lysis buffer for 30 min and centrifuged at 8000 rpm for 10 min. The supernatants were transferred into a streptavidin-coated microplate and incubated with biotin-conjugated anti-histone and peroxidase-conjugated anti-DNA monoclonal antibodies for 2 h. After washing, ABTS substrate solution was added to each well for 15 min. Absorbance was measured at 405 and 490 nm. The specific enrichment of mono-and oligonucleosomes was calculated as enrichment factor EF ð Þ ¼ absorbance of HSV À À infected cells=absorbance of corresponding non À À infected control cells:
Western blot assays
Cells were homogenized in CytoBuster lysis buffer (Novagen, EMD Biosciences, Darmstadt, Germany), and the mixture was then centrifuged at 10,000g for 10 min to remove cell debris. Protein concentrations of cell lysates were determined by using the Bio-Rad protein assay (BioRad, Hercules, CA, USA). Supernatants were mixed with Laemmli's sample buffer and boiled for 3 min. Aliquots of the supernatants, containing 50 μg of total protein to detect LC3B were resolved by SDS-PAGE and electrotransferred onto nitrocellulose filters (Bio-Rad). Preblocked blots were reacted with polyclonal antibody against LC3B (Sigma) for 4 h in PBS containing 0.05% Tween 20, 1% dried non-fat milk (Difco Laboratories, Detroit, MI, USA) and 1% BSA (Sigma). Blots were then incubated for 2 h with peroxidase-conjugated anti-rabbit antibody (DakoCytomation, Carpinteria, CA, USA). Filters were developed by using a chemiluminescence detection system (Thermo Fisher Scientific Inc., Rockford, IL, USA). The autoradiographs were scanned with a GS-800 densitometer (Bio-Rad), and the relative band intensities were quantified by use of the ImageQuant software (Molecular Dynamics, Sunnyvale, CA, USA).
Statistical analysis
All values are expressed as mean ± standard deviation (SD). The one-way ANOVA test with the Bonferroni post-test was used for pairwise multiple comparisons, and p-values < 0.05 were considered statistically significant (GraphPad Prism 5, GraphPad Software Inc., La Jolla, CA, USA).
Results
Effects of HSV-1 and HSV-2 on autophagy in the SIRC cell line
To investigate the susceptibility of SIRC cells to the KOS strain of HSV-1 and a wild-type HSV-2 strain, virus multiplication was assessed by using indirect immunofluorescence assay, Western blot and plaque titration. The data demonstrated that both HSV-1 and HSV-2 could establish a productive infection in this cell line (data not shown; Orosz et al. 2010) .
To study the effects of HSV-1 and HSV-2 on the process of autophagy, SIRC cells were infected either with HSV-1 or HSV-2 at an MOI of 1 and analysed by TEM and immunofluorescence assay at 24 hpi.
TEM examination of the mock-infected culture revealed normal cell morphology ( figure 1A ). In contrast, there were numerous intracytoplasmic vacuoles in HSV-1-infected cells (figures 1B-D). These vacuolar structures contained amorphous materials, organelles or virion particles (figures 1B-D). The vacuoles were dispersed in the cytoplasm evenly ( figures 1B-D) . This finding corresponds to the TEM picture of excessive autophagy. This test has also provided experimental proof of ongoing viral replication in SIRC cells, as numerous assembled capsids and primarily enveloped virions were revealed in the nuclei of infected cells. Some fully matured cytoplasmic capsids and virions released from the cell in exocytotic vesicles were also detected (figures 1B-D).
Indirect immunofluorescence assay to investigate the effect of HSV-1 on the intracellular localization of Atg5 and LC3B revealed diffuse, cytoplasmic staining patterns in the mock-infected cultures ( figures 1E and G, respectively) . In contrast, HSV-1 increased the intensity of staining and triggered translocation of Atg5 and LC3B from the cytoplasm to distinct puncta in 67% and 93% of cells, respectively ( figures 1F and H, respectively) . Together, these data demonstrate that HSV-1 triggers the formation of autophagic vacuoles, and alters the intracellular localization of Atg5 and LC3B.
To investigate the autophagic flux, bafilomycin A1 (BFLA) was used as a pharmacological tool to inhibit lysosomal degradative activity and to prevent fusion of autophagosomes with lysosomes. As BFLA decreased the production of infectious virions severely when it was present throughout the infection (data not shown), an experimental strategy that allows adsorption and uncoating to proceed undisturbed was applied (figure 2A) (Harley et al. 2001 ). The cells were infected either with HSV-1 or HSV-2 at an MOI of 20, and incubated for 3 h. The cultures were then treated with BFLA for an additional 12 h period, and analysed for viral yields, apoptosis and LC3B expression ( figure 2A ). Western blot analysis to quantify intracellular gD protein revealed two bands migrating near 52 and 56 kDa in HSV-1-or HSV-2-infected cells ( figure 2B ). This result is fully consistent with previous observations demonstrating that gD migrates as a doublet; the~52 and~56 kDa polypeptides correspond to the nonglycosylated and fully glycosylated forms of gD, respectively (Balachandran et al. 1982; Isaacs et al. 2000; Gianni et al. 2009 ). BFLA inhibited the accumulation of this envelope glycoprotein in HSV-1-or HSV-2-infected cells by 12.3% and 42.5%, respectively (figure 2B). Plaque assay to quantify viral multiplication revealed that BFLA retarded replication of HSV-1 and HSV-2 by 52.6% and 13.6%, respectively (figure 2C). Thus, the strategy involving delayed addition of BFLA provided conditions when productive infection has occurred, though at diminished levels compared to infected cultures incubated in the absence of this autophagy inhibitor. Western blot analysis to measure the levels of the lipidated and nonlipidated forms of LC3B demonstrated that the mockinfected culture displayed endogenous expression both of LC3B-II and LC3B-I; the LC3B-II / LC3B-I ratio was 0.17 at 15 h of culturing ( figure 2D, lane 6 ). Cells infected with HSV-1 and HSV-2 displayed elevated LC3B-II and depressed LC3B-I levels; the LC3B-II / LC3B-I ratios were 0.82 and 0.56, respectively (figure 2D, lanes 2 and 4, respectively). This result demonstrates that HSV-1 and HSV-2 promote LC3B lipidation. BFLA highly elevated the level of LC3B-II ( figure 2D, lane 1) , indicating that this drug efficiently blocked autophagy under the experimental conditions used, and the pathways promoting LC3B-II accumulation are intact in the SIRC cell line. In the presence of BFLA, HSV-1 and HSV-2 triggered slightly lower increase in the level of LC3B-II than that observed in the corresponding drug control ( figure 2D, lanes 3, 5 and 1, respectively) . Thus, both HSV-1 and HSV-2 decrease the autophagic flux to some extent.
Acridine orange staining to detect autophagic vacuoles revealed green cytoplasmic and nuclear staining in the mock-infected cells at 24 h of culturing ( figure 3A) . The nuclei of mock-infected cells were mostly round in shape ( figure 3A) . In contrast, cells infected with HSV-1 or HSV-2 at an MOI of 1 displayed green nuclear and strong red cytoplasmic fluorescence at 24 hpi, demonstrating that both HSV types promote cytoplasmic acidification ( figure 3A) . In HSV-1-infected cultures a few small syncytia, containing <5 nuclei, were observed, while HSV-2 infection resulted in the formation of numerous large multinucleated giant cells, which contained >50 nuclei ( figure 3A) . The nuclei of infected cells had markedly irregular shape, contained disorganized chromatin structures, and in some areas blurring, folding or complete disruption of the nuclear membrane was also observed (figure 3A).
Cell death pattern of HSV-1-and HSV-2-infected SIRC cells
To investigate the cytopathogenicity of HSV-1 and HSV-2 in SIRC cultures, the cell death pattern of cultures infected at an MOI of 1 was determined by AN/PI double labelling at 24 hpi. Both HSV-1 and HSV-2 decreased the proportions of viable cells by 32.9% and 57.8%, respectively (figure 3B). The proportions of AN-single-positive (early apoptotic) and double-positive (late apoptotic or secondary necrotic) cells in HSV-1-infected cultures were increased by 15.4% and 13.3%, respectively (figure 3B). The proportions of double-positive and PI-single positive (necrotic) cells were increased by 36.5% and 23.8% in HSV-2-infected cultures, respectively ( figure 3B ). Together, these data reveal that both HSV-1 and HSV-2 trigger extensive cell demise.
Inhibition of autophagy increases apoptotic rates of SIRC cells infected with HSV-1 and HSV-2
To investigate the potential connection between autophagy and apoptosis, the effect of the autophagy inhibitor BFLA on the extent of apoptosis was assessed. The cells were infected either with HSV-1 or HSV-2 at an MOI of 20, and incubated for 3 h. The cultures were then treated with BFLA for an additional 12 h period, and analysed for apoptosis by ELISA. The assay revealed significantly higher apoptotic rates in HSV-1-and HSV-2-infected cells; the EFs for HSV-1 and HSV-2 were 2.86 and 2.93, respectively (figure 4). EFs for the HSV-1-and HSV-2-infected cells incubated in the presence of BFLA were 6.36 and 4.32 vs 2.86 and 2.93 for the HSV-1-and HSV-2-infected cells incubated in the absence of drug, respectively (figure 4). Thus, BFLA triggered a significant increase in the apoptotic responses of HSV-1-and HSV-2-infected cells as compared with the corresponding infected controls incubated in the absence of drug. Moreover, there was a significant difference between the apoptosis inducing activities of HSV-1 and HSV-2 in BFLA-treated cells (figure 4). Together, these results demonstrate that inhibition of autophagy facilitates apoptosis induced by HSV-1 and HSV-2.
Discussion
Apoptosis and autophagy are implicated in the maintenance of ocular surface integrity both in physiological and pathological conditions (Wilson 1999; Vemuganti et al. 2004; Buron et al. 2006; Zoukhri et al. 2008) . Compelling evidence indicates that apoptosis is instrumental in glaucoma, retinitis pigmentosa, cataract, retinoblastoma, retinal ischemia, diabetic retinopathy and several eye infections caused by viruses, bacteria, fungi and some protozoans (Kaneda et al. 1999; Vemuganti et al. 2004; Cottet and Schorderet 2009; Zhang et al. 2010; Poznic M 2009; Barber et al. 2011; Pinazo-Durán et al. 2013) . In contrast, we are just beginning to understand the role of autophagy in ocular diseases. As herpetic keratitis continues to be a frequent and serious medical problem, in this study we have investigated the role of apoptosis and autophagy in the pathogenic mechanism of direct corneal damage triggered by HSV-1 and HSV-2 in the SIRC corneal cell line. Remarkable studies focusing on the function of corneal keratocytes in the maintenance of visual integrity have clearly demonstrated that keratocytes, located in the corneal stroma as a highly interconnected cellular network, undergo apoptotic cell demise immediately after infections (Vemuganti et al. 2004; West-Mays et al. 2006) . The apoptotic response of keratocytes operates as an important antiviral mechanism by inhibiting the spread of viruses to deeper structures of the eye, and minimizes the inflammation that accompanies corneal injury (Wilson et al. 1997 ; Vemuganti e t a l . 2 0 0 4 ; M o r i s h i g e e t a l . 2 0 0 6 ; Ambrósio et al. 2009 ). In full accord with these findings our data have corroborated that both HSV-1 and HSV-2 trigger apoptosis in corneal cells.
Further interesting studies have demonstrated that the effect of HSV-1 on autophagy is cell-type-specific. While HSV-1 activates the STING (stimulator of interferon genes)-dependent autophagy pathway in murine macrophages and dendritic cells, neuroblastoma cells respond to HSV-1 infection with an abortive autophagy, and the anti-autophagic effects of ICP34.5 and Us11 proteins dominate in fibroblasts and primary murine neurons (Tallóczy et al. 2001; Tallóczy et al. 2006; Orvedahl et al. 2007; Santana et al. 2012; Lussignol et al. 2013) . However, the impact of HSV infection on the autophagic process has not yet been elucidated in corneal cells. Our analyses have revealed that HSV-1 facilitates the accumulation of autophagosomes, as well as the recruitment of LC3B and Atg5 to autophagic vacuoles in the SIRC cell line. Our further experiments have also shown that both HSV-1 and HSV-2 trigger LC3B lipidation, and increase cytoplasmic acidification, without enhancing the autophagic flux. Together, these results demonstrate that autophagy is induced by both HSV-1 and HSV-2 in spite of their effective anti-autophagic armamentarium, which possibly impedes the process considerably via inhibiting the fusion of autophagosomes with lysosomes.
Recent findings demonstrated that the apoptotic, autophagic and necrotic pathways are interconnected and subject to coordinated regulation (Jain et al. 2013) . Autophagy can operate as antagonist, facilitator or cooperator of apoptosis depending on the nature of stressor and cellular context (Jain et al. 2013 ). It has also been shown that HSV-1 elicits an mTOR-independent pathway of autophagy, which in turn prolongs survival of U251 glioma cells by counteracting the coinciding apoptotic response (Tovilovic et al. 2013) . Thus, next we have asked whether autophagy has the potential to modulate apoptotic demise during the course of HSV-1 and HSV-2 infection. Our results have revealed that apoptotic cell demise induced by both HSV-1 and HSV-2 is markedly enhanced by inhibition of autophagy indicating that autophagy acts as antagonist of apoptosis in HSVinfected SIRC cells. Induction of autophagy by HSV-1 and HSV-2 may represent a viral strategy to provide sufficient time for replication via inhibiting untimely apoptotic demise. These data corroborate previous findings obtained with HSV-1-infected U251 glioma cultures (Tovilovic et al. 2013) , and extend the spectrum of cells in which HSVmediated induction of autophagy alleviates apoptosis. Under circumstances when apoptosis is blocked, viral replication can proceed in an undisturbed fashion, and the inevitable demise of HSV-infected cells may preferably occur by way of necrosis. This type of cell death may trigger a strong proinflammatory response and thereby it may contribute to the development of characteristic clinical symptoms seen in keratitis patients. Together, these results may bear on keratitis, since dysregulation of keratocyte apoptosis may account for the structural and functional damage of cornea occurring during the course of HSV infection. Moreover, our further observation demonstrating a more remarkable anti-apoptotic effect of autophagy in cultures infected with HSV-1 than in HSV-2-infected cells suggests that the mechanism of corneal cytopathogenicity evoked by the two HSV types might involve some different molecular mechanisms.
A better understanding of intrinsic autophagy evolving during the course of herpes simplex keratitis and other infections caused HSV-1 and HSV-2 may provide useful knowledge for the development of novel therapeutic modalities acting through autophagy modulation. A recent interesting study revealed that rapamycin used topically in a mouse model of HSK suppressed inflammation and neovascularization (Zapata et al. 2012) . In view of our present findings obtained by using an in vitro SIRC corneal cell model system, it is reasonable to infer that the beneficial therapeutic efficiency of autophagy inducers in herpetic keratitis may partly be due to their ability to reduce tissue damage via counteracting apoptotic demise of infected cells.
Overall, this study demonstrates that HSV-1 and HSV-2 affect autophagy and apoptosis in a coordinated fashion, and autophagy antagonizes apoptosis in HSV-infected cells. Together these data implicate autophagy in the pathogenic mechanisms of herpetic keratitis. Foundation, the Research Council of Norway, the Norwegian Center for Stem Cell Research, the Norwegian Association of the Blind and Partially Sighted, Blindemisjonen IL, the Faculty of Medicine University of Oslo and Oslo University Hospital.
